These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30428602)

  • 21. Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging.
    Voges I; Bräsen JH; Entenmann A; Scheid M; Scheewe J; Fischer G; Hart C; Andrade A; Pham HM; Kramer HH; Rickers C
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):e272-9. PubMed ID: 23818571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1α loaded proteolytically degradable hydrogel for recellularization and remodeling.
    Dai J; Qiao W; Shi J; Liu C; Hu X; Dong N
    Acta Biomater; 2019 Apr; 88():280-292. PubMed ID: 30721783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
    Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
    J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials.
    Engelmayr GC; Hildebrand DK; Sutherland FW; Mayer JE; Sacks MS
    Biomaterials; 2003 Jun; 24(14):2523-32. PubMed ID: 12695079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study.
    Zhao DE; Li RB; Liu WY; Wang G; Yu SQ; Zhang CW; Chen WS; Zhou GX
    Asian Cardiovasc Thorac Ann; 2003 Jun; 11(2):153-6. PubMed ID: 12878565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering.
    Sodian R; Sperling JS; Martin DP; Egozy A; Stock U; Mayer JE; Vacanti JP
    Tissue Eng; 2000 Apr; 6(2):183-8. PubMed ID: 10941212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term evaluation of thromboresistance of a poly(ether ether ketone) (PEEK) mechanical heart valve with poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC)-grafted surface in a porcine aortic valve replacement model.
    Kambe Y; Mahara A; Tanaka H; Kakinoki S; Fukazawa K; Liu Y; Kyomoto M; Minatoya K; Ishihara K; Yamaoka T
    J Biomed Mater Res A; 2019 May; 107(5):1052-1063. PubMed ID: 30688402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model.
    Emmert MY; Schmitt BA; Loerakker S; Sanders B; Spriestersbach H; Fioretta ES; Bruder L; Brakmann K; Motta SE; Lintas V; Dijkman PE; Frese L; Berger F; Baaijens FPT; Hoerstrup SP
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model.
    Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species-specific effects of aortic valve decellularization.
    VeDepo MC; Buse EE; Quinn RW; Williams TD; Detamore MS; Hopkins RA; Converse GL
    Acta Biomater; 2017 Mar; 50():249-258. PubMed ID: 28069510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Collagen Remodeling in the Vascular Wall of Decellularized Stented Tissue-Engineered Heart Valves.
    Ghazanfari S; Driessen-Mol A; Sanders B; Dijkman PE; Hoerstrup SP; Baaijens FP; Bouten CV
    Tissue Eng Part A; 2015 Aug; 21(15-16):2206-15. PubMed ID: 26028124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model.
    Weber B; Dijkman PE; Scherman J; Sanders B; Emmert MY; Grünenfelder J; Verbeek R; Bracher M; Black M; Franz T; Kortsmit J; Modregger P; Peter S; Stampanoni M; Robert J; Kehl D; van Doeselaar M; Schweiger M; Brokopp CE; Wälchli T; Falk V; Zilla P; Driessen-Mol A; Baaijens FP; Hoerstrup SP
    Biomaterials; 2013 Oct; 34(30):7269-80. PubMed ID: 23810254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Novel Human Cell-Derived Tissue-Engineered Heart Valve for Transcatheter Aortic Valve Replacement: an In Vitro and In Vivo Feasibility Study.
    Lintas V; Fioretta ES; Motta SE; Dijkman PE; Pensalfini M; Mazza E; Caliskan E; Rodriguez H; Lipiski M; Sauer M; Cesarovic N; Hoerstrup SP; Emmert MY
    J Cardiovasc Transl Res; 2018 Dec; 11(6):470-482. PubMed ID: 30105605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous pulmonary valve replacement using completely tissue-engineered off-the-shelf heart valves: six-month in vivo functionality and matrix remodelling in sheep.
    Schmitt B; Spriestersbach H; O H-Icí D; Radtke T; Bartosch M; Peters H; Sigler M; Frese L; Dijkman PE; Baaijens FP; Hoerstrup SP; Berger F
    EuroIntervention; 2016 May; 12(1):62-70. PubMed ID: 27173864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro assessment of the functional performance of the decellularized intact porcine aortic root.
    Korossis SA; Wilcox HE; Watterson KG; Kearney JN; Ingham E; Fisher J
    J Heart Valve Dis; 2005 May; 14(3):408-21; discussion 422. PubMed ID: 15974537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Tri-Leaflet Nitinol Mesh Scaffold for Engineering Heart Valves.
    Alavi SH; Soriano Baliarda M; Bonessio N; Valdevit L; Kheradvar A
    Ann Biomed Eng; 2017 Feb; 45(2):413-426. PubMed ID: 28008545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model.
    Fallon AM; Goodchild TT; Cox JL; Matheny RG
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):333-340.e1. PubMed ID: 24360254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model.
    Emmert MY; Weber B; Wolint P; Behr L; Sammut S; Frauenfelder T; Frese L; Scherman J; Brokopp CE; Templin C; Grünenfelder J; Zünd G; Falk V; Hoerstrup SP
    JACC Cardiovasc Interv; 2012 Aug; 5(8):874-83. PubMed ID: 22917460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
    Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural assessments in decellularized extracellular matrix of porcine semilunar heart valves: Evaluation of cell niches.
    Roderjan JG; de Noronha L; Stimamiglio MA; Correa A; Leitolis A; Bueno RRL; da Costa FDA
    Xenotransplantation; 2019 May; 26(3):e12503. PubMed ID: 30770594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.